The major players operating in the global membrane chromatography market are Sartorius (Germany), GE Healthcare (US), Danaher (US), and Merck Millipore (US). The global membrane chromatography market is expected to reach USD 290.6 million by 2022 from USD 126.6 million in 2017, at a CAGR of 18.1%. The increasing demand for biopharmaceuticals, increasing R&D expenditure in the biopharmaceutical industry, increasing regulatory scrutiny on the cleaning validation of downstream purification processes, and significant benefits of membrane chromatography over conventional chromatography methods are the major factors driving the growth of the membrane chromatography market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=151487196
Most companies focus on expansions and acquisitions to compete in the market. The players also focus on increasing their presence in high-growth markets through new product launches and synergetic collaborations. Sartorius (Germany), Danaher (US), GE Healthcare (US), and Merck Millipore (US) focus on acquisitions to strengthen their position in the market.
Sartorius Stedim Biotech is the leading player in the global membrane chromatography market. The company focuses on organic and inorganic strategies, such as product launches, acquisitions, and expansions to strengthen its position in the market. For instance, in 2017, Sartorius AG invested USD 33.9 million in its German laboratory and facility, to develop cell lines and protein production. With its strong geographic presence and extensive product portfolio, the company has witnessed strong growth in the membrane chromatography market.
Danaher is one of the leading players operating in the membrane chromatography market. The company offers an extensive product portfolio through its Life Science business segment across the globe with a significant presence in countries including the US, China, Germany, and Japan. The company focuses acquisitions to strengthen its product portfolio. For instance, in 2017, the company acquired Phonomenex (US) to strengthen its chromatography business and R&D activity.
Merck Millipore stands among the leading players in the membrane chromatography market across more than 66 countries including Europe, North America, Asia Pacific, and the Middle East and Africa. The company offers membrane chromatography products ranging from capsules, filter plates, syringe filters, and accessories for biopharmaceutical manufacturing and process development in R&D. In 2017, the company expanded its membrane chromatography product portfolio through the acquisition of Natrix Separations and accelerated its offering for mAb and vaccine manufacturing. This acquisition resulted in a significant increase in Merck Millipore’s share in the membrane chromatography market.
